offline
Healthcare | Drug Manufacturers - Major | United Kingdom
Glaxo (GSK) Beats Earnings & Revenue Estimates in Q4
...
Earnings Beat: Glaxo reported core earnings of 80 cents per American depositary share in the fourth quarter of 2018, which beat our consensus estimate of 70 cents. The company’s focus on cost control initiative has boosted margins.
Revenues Beat: Revenues were up 5% year over year at constant exchange rate (CER) to $10.54 billion (£8.2 billion). Revenues beat the Zacks Consensus Estimate of $9.85 billion.
Key Stats: While sales in Consumer Healthcare and Pharmaceuticals were up 1% and 4%. respectively, the Vaccines segment increased 18% at CER. Glaxo acquired TESARO and announced agreement with Merck KGaA to add oncology products to its pharma portfolio.
2019 Guidance: Glaxo expects EPS to decline by 5-9% at CER in 2019 which includes impact of Advair generic, acquisition of TESARO, joint venture with Pfizer for Consumer Healthcare business ad divestment of certain nutrition brands.
...
https://finance.yahoo.com/news/glaxo-gsk...01203.html
![[Bild: GSKc1dl1443.png]](https://finviz.com/publish/020619/GSKc1dl1443.png)
Glaxo (GSK) Beats Earnings & Revenue Estimates in Q4
...
Earnings Beat: Glaxo reported core earnings of 80 cents per American depositary share in the fourth quarter of 2018, which beat our consensus estimate of 70 cents. The company’s focus on cost control initiative has boosted margins.
Revenues Beat: Revenues were up 5% year over year at constant exchange rate (CER) to $10.54 billion (£8.2 billion). Revenues beat the Zacks Consensus Estimate of $9.85 billion.
Key Stats: While sales in Consumer Healthcare and Pharmaceuticals were up 1% and 4%. respectively, the Vaccines segment increased 18% at CER. Glaxo acquired TESARO and announced agreement with Merck KGaA to add oncology products to its pharma portfolio.
2019 Guidance: Glaxo expects EPS to decline by 5-9% at CER in 2019 which includes impact of Advair generic, acquisition of TESARO, joint venture with Pfizer for Consumer Healthcare business ad divestment of certain nutrition brands.
...
https://finance.yahoo.com/news/glaxo-gsk...01203.html
